About

Who we are

DNA-poli was devised by prof. dr. Peter van Tintelen, renowned cardiogeneticist and key-opinion leader. It has been developed since 2020 within a Dutch scientific consortium, including world-class clinical genetics departments at the Utrecht and Amsterdam academic hospitals in collaboration with conversational AI-specialists from Twente University and a public-private partnership with KAESS design agency.

Our mission

Hereditary genetic conditions affect entire families, yet many at-risk relatives receive inadequate care causing avertable harm. We are dedicated to make Clinical Genetic counseling and DNA-testing more accessible to everyone, eliminating waiting lists and empowering relatives to make well informed decisions about their personal health.

With DNA-Poli, we provide a secure and scalable digital platform for healthcare providers to communicate curated information with affected families, giving at-risk relatives a clear path from risk awareness to genetic counseling and specialist care.

See our services

16% better reach

Improve counseling uptake after 6 months from 37% to 53%*

Increased efficiency

Maintain quality of care - reduce counseling times by about 30 minutes*

Eliminate waiting lists

Increase your production and decrease patient anxiety

Global impact

Designed to improve genetic care world-wide

* based on interim trial results

Our values

Patient-centered

Every feature is designed around the patient journey and reviewed by our patient council — from first contact to DNA-testing and follow-up.

Clinically grounded

Built by Clinical Geneticists at leading academic hospitals to solve pressing challenges in day-to-day clinical practice.

Compliant & secure

Designed with safety- and security first, we comply with required regulations and go beyond industry standards to keep sensitive health data safe.

Collaborative

Jointly developed by healthcare professionals and patients and continuously improved through feedback and shared expertise.

Our Team

Prof. Peter van Tintelen

Prof. MD PhD

Chair, Advisory Board

Dr. Marten Siemelink

MD PhD

CEO

Thomas van Rompaey

CTO

Collaborators

Scientific

UMC Utrecht — Genetica

Marlies van Lingen, Lieke M. van den Heuvel, Prof. J. Peter van Tintelen

University of Twente — Human Media Interaction

Tessa Beinema, Jan Kolkmeier, Randy Klaassen, Prof. Dirk K.J. Heylen

Netherlands Cancer Institute, Amsterdam

Noor A.A. Giesbertz

Amsterdam UMC

Prof. M. Corrette Ploem, Prof. Martina Cornel

Bureau KAESS BV

Dianne van Essen, Martijn Kampshoff

Clinical

UMC Groningen

Karin van Spaendonck-Zwarts, Imke Christiaans

Radboud UMC & Maastricht UMC

Yvonne Hoedemaekers, Ingrid Krapels, Angela van Remortele